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Abstract
We have previously demonstrated (1) an increased expression of caveolin-1 in murine heterozygous and homozygous
Niemann-Pick type C (NPC) livers, and (2) an increased concentration of unesterified cholesterol in a detergent insoluble
caveolae-enriched fraction from homozygous livers. To define further the relationship between caveolin-1 function and the
cholesterol trafficking defect in NPC, we examined the expression and distribution of additional caveolar and signal
transduction proteins. The expression of annexin II was significantly increased in homozygous liver homogenates and the
Triton X-100 insoluble floating fraction (TIFF). Phosphoamino acid analysis of caveolin-1 and annexin II from the
homozygous TIFF demonstrated an increase in serine and tyrosine phosphorylation, respectively. To determine the basis for
increased phosphorylation of these proteins, the expression and distribution of several protein kinases was examined. The
expression of PKCK, PKCj and pp60-src (protein kinases) were significantly increased in both heterozygous and
homozygous liver homogenates, while PKCN was increased only in homozygous livers. Of the protein kinases analyzed, only
CK IIK was significantly enriched in the heterozygous TIFF. Finally, the concentration of diacylglycerol in the homozygous
TIFF was significantly increased and this elevation may modulate PKC distribution and function. These results provide
additional evidence for involvement of a caveolin-1 containing cellular fraction in the pathophysiology of NPC and also
suggest that the Npc1 gene product may directly or indirectly, regulate the expression and distribution of signaling
molecules. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Niemann-Pick type C (NPC) disease is an autoso-
mal recessive lipid storage disorder characterized by
hepatosplenomegaly and neurological deterioration
[1]. Elevated intracellular cholesterol is the major
biochemical ¢nding in NPC. NPC ¢broblasts grown
in media with low density lipoprotein (LDL) accu-
mulate unesteri¢ed cholesterol within lysosomes and
the trans-Golgi cisternae [2,3]. The inability of unes-
teri¢ed cholesterol to tra⁄c to speci¢c intracellular
compartments is responsible for the dysregulation of
cholesterol metabolism seen in this disorder [4,5].
Recently, the NPC genes from both human (NPC1)
and mouse (Npc1) were cloned, and the gene product
determined to be an integral membrane protein with
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regions homologous to the Hedgehog signaling mol-
ecule PATCHED and to the sterol-sensing domain
associated with 3-hydroxy-3-methylglutaryl coen-
zyme A (HMG-CoA) reductase [6,7]. Although the
subcellular location and function of the NPC1 pro-
tein is unknown, speci¢cally its role in intracellular
cholesterol movement, de¢nition of its function is
under intense investigation.
Our previous studies demonstrated an altered ex-
pression of caveolin-1 in livers from heterozygous
and homozygous mice with NPC [8]. Caveolin-1 is
a cholesterol-binding protein that serves a structural
role in the formation of plasma membrane caveolae
which are membrane domains that participate in po-
tocytosis, transcytosis and signal transduction [9^11].
Recently, caveolae have been shown to participate in
cholesterol tra⁄cking [12]. Incubation of cultured
¢broblasts with cholesterol oxidase results in caveo-
lin-1 cycling from the plasma membrane to the en-
doplasmic reticulum and back to the plasma mem-
brane through the Golgi [13,14]. Other studies show
that caveolin-1 facilitates the transport of unesteri-
¢ed cholesterol to plasma membrane caveolae where
it then becomes available for e¥ux, a mechanism
presumably important for maintaining intracellular
cholesterol homeostasis [12,13,15]. Our demonstra-
tion that caveolin-1 is altered in NPC suggests that
a caveolin-1 containing cellular component is in-
volved in the NPC cholesterol tra⁄cking defect.
Like caveolin-1, annexin II has been found to be
associated with caveolae and intracellular vesicles
[16^18]. Structurally, annexin II contains a highly
conserved C-terminal domain responsible for facili-
tating Ca2-dependent association with negatively
charged phospholipids [19]. Recent studies show
that the N-terminal domain participates in cholester-
ol-dependent binding within cholesterol-rich mem-
brane domains including caveolae [20]. Annexin II
may, therefore, be important for caveolar structure
and function.
It appears that phosphorylation is important in
regulating the function of both caveolin-1 and annex-
in II. Both caveolin-1 and annexin II contain protein
kinase C (PKC) phosphorylation consensus sequen-
ces, although only annexin II serves as a direct sub-
strate for PKC [21,22]. Caveolin-1 is, instead, serine
phosphorylated by casein kinase IIK (CK IIK), which
is, in turn, activated by PKC [23]. Tyrosine phos-
phorylation of both proteins can be mediated by
pp60-src [24,25]. Both CK IIK and pp60-src are
found in caveolae and are thus poised to modulate
caveolae structure and function possibly through
phosphorylation of caveolin-1 and annexin II [11,26].
Results obtained in the present study indicate that
the expression of annexin II in homozygous liver
homogenates is increased and that caveolin-1 and
annexin II associated with the homozygous Triton
X-100 insoluble £oating fraction (TIFF) are in-
creased in serine and tyrosine phosphorylation, re-
spectively. To help determine the underlying mecha-
nism responsible for caveolin-1 and annexin II
phosphorylation, we examined and found alterations
in expression and distribution of speci¢c protein kin-
ases (PKCK, PKCN, PKCO and PKCh, PKA-cs,
pp60-src and CK IIK). The alteration found in the
expression of these kinases may help to de¢ne further
the basis of the defective intracellular cholesterol
tra⁄cking in NPC.
The additional ¢ndings of alterations in annexin II
and kinase expression suggest that a caveolin-1 con-
taining cell component is involved in the pathophysi-
ology of NPC, and that alterations in intracellular
signaling mechanisms are an important pathophysio-
logical consequence of NPC.
2. Methods
2.1. Animals
Two breeding pairs of BALB/c heterozygous Nie-
mann-Pick type C (NPC) mice were the generous gift
of Dr. Peter Pentchev from the National Institute of
Health. These mice were bred to produce a¡ected
o¡spring and additional heterozygotes. Mice were
identi¢ed as homozygous a¡ected when symptoms
of NPC developed and as heterozygous by the pro-
duction of a¡ected o¡spring. Homozygous normal
BALB/c mice were purchased and bred separately
from the NPC colony. Animals were killed using
cervical dislocation, and the livers were removed
and stored frozen at 370‡C. Males and females
were equally represented. Homozygous normal mice
were killed between the ages of 1.5 and 12 months.
Homozygous a¡ected mice were killed between the
time of diagnosis (W1.5 months) and death (W2.5
BBADIS 61801 11-2-99
W.S. Garver et al. / Biochimica et Biophysica Acta 1453 (1999) 193^206194
months). Heterozygous mice were killed between the
ages of 3 and 12 months. Animals were maintained
at the University of Arizona Animal Care facility on
mouse chow containing 6% fat and water ad libitum.
2.2. Reagents
Cholesterol, phosphatidylcholine (dioleoyl), lyso-
phosphatidylcholine (oleoyl), phosphatidylethanol-
amine (dioleoyl), phosphatidylserine (dioleoyl), 1,2-
dioleoylglycerol, sphingomyelin (oleoyl), pepstatin,
leupeptin, aprotinin and bovine albumin (fraction
V) were purchased from Sigma (St. Louis, MO). Gla-
cial acetic acid, hexane, isopropanol and chloroform
were purchased from Fisher Scienti¢c (Pittsburgh,
PA). Diethyl ether was obtained from Aldrich (Mil-
waukee, WI). Bicinchoninic acid (BCA) protein assay
reagent and SuperSignal Substrate for Western blot-
ting were purchased from Pierce Chemical (Rock-
ford, IL). Cholesterol oxidase was purchased from
Calbiochem (La Jolla, CA) and horseradish peroxi-
dase from Boehringer Mannheim (Indianapolis, IN).
A⁄-Gel Protein A Gel agarose was purchased from
Bio-Rad Laboratories (Hercules, CA). Mouse anti-
caveolin-1, mouse anti-annexin II, mouse anti-PKC
(K, N, O and j isotypes), and casein kinase IIK (CK
IIK) were purchased from Transduction Laboratories
(Lexington, KY). Mouse anti-pp60-src was pur-
chased from Oncogene Research Products (Cam-
bridge, MA). Mouse anti-phosphoserine and anti-
phosphotyrosine were purchased from Sigma (St.
Louis, MO). Peroxidase-conjugated anti-mouse IgG
was purchased from Kirkegaard and Perry Labora-
tories (Gaithersburg, MD).
2.3. Isolation of the TIFF
The TIFF from mouse livers was isolated as pre-
viously described [27]. Brie£y, mouse liver was
minced using a razor blade, followed by homogeni-
zation in 10 ml of ice-cold bu¡er A (0.025 M MES,
pH 6.5, 1.0 mM EDTA, 10 WM each of PMSF, pep-
statin, leupeptin and aprotinin) using a motor-driven
Dounce homogenizer. The homogenate was centri-
fuged at 500Ug for 10 min to remove nuclei and
cell debris. The resulting post-nuclear supernatant
was centrifuged at 100 000Ug for 1 h to obtain a
pellet representing the total membrane preparation.
This pellet was solubilized in 2 ml of ice-cold bu¡er
A containing 150 mM NaCl and 1% Triton X-100
(bu¡er B) using needle aspiration. A sucrose step
gradient was generated using 1.5 ml 42% sucrose,
3.0 ml 25% sucrose and 3.5 ml 15% sucrose in bu¡er
B containing 0.5% Triton X-100 at 4‡C, followed by
layering 2.0 ml of the detergent solubilized mem-
branes on top of the sucrose step gradient and cen-
trifuged at 100 000Ug for 2 h at 4‡C. The TIFF
migrated to the 15^25% sucrose interface and the
opalescent interface was collected directly using nee-
dle aspiration. Collected fractions were concentrated
using Centricon-10 concentrators (Amicon, Beverly,
MA) in preparation for immunoblot analysis, immu-
noprecipitation and lipid analysis.
2.4. Immunoprecipitation of caveolin-1 and annexin II
TIFF-derived protein (500 Wg) from normal, het-
erozygous and homozygous mouse livers was solubi-
lized using 1.0 ml of bu¡er C (0.010 M Tris, pH 7.4,
0.150 M NaCl, 1.0 mM EDTA, 0.5% Triton X-100,
30 mM CHAPS, 10 mM NaF and protease inhibi-
tors) for 1 h at 4‡C followed by centrifugation at
100 000Ug for 1 h. Supernatants were precleared us-
ing 50 Wl of 10% Protein A-agarose for 2 h at 4‡C
followed by overnight nutation at 4‡C with either
mouse anti-caveolin-1 or anti-annexin II (5.0 Wg).
Protein A-agarose (50 Wl) was added and allowed
to nutate for an additional 2 h at 4‡C to initiate
immunoprecipitation. The agarose beads were then
rinsed 4 times with 1.0 ml of bu¡er C. Immunopre-
cipitated protein was solubilized from the agarose
beads using SDS-PAGE sample bu¡er under reduc-
ing conditions and boiled for 5 min before electro-
phoresis.
2.5. Immunoblot analysis
Samples were separated using 10% SDS-PAGE
under reducing conditions and transferred to a nitro-
cellulose membrane. In most instances, immunoblot
bu¡er D (0.010 M sodium phosphate, pH 7.4, 0.150
M NaCl, 0.05% Tween 20 and 4% non-fat dry milk)
was used for blocking non-speci¢c sites for 2 h at
room temperature. When probing for the presence
of phosphotyrosine, immunoblot bu¡er E (0.010 M
sodium phosphate pH 7.4, 0.150 M NaCl, 0.05%
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Tween 20 and 2% bovine albumin) was used for 3 h
at room temperature. Immunoblots were routinely
performed by incubating with antibody overnight
at 4‡C. Blots were rinsed 3U for 10 min, then incu-
bated with peroxidase-conjugated goat anti-mouse
IgG (1:5000 dilution in the appropriate blocking
bu¡er) for 1 h at room temperature. After rinsing
3U for 10 min, the immunoblots were incubated in
SuperSignal Substrate solution for 5 min and en-
hanced chemiluminescence (ECL) was detected using
Kodak BioMax MR Scienti¢c Imaging Film. Signals
were quantitated using a Bio-Rad Model GS-700
Imaging Densitometer.
2.6. Phosphoamino acid analysis of caveolin-1 and
annexin II
To measure the phosphorylation of caveolin-1 and
annexin II, these proteins were ¢rst immunoprecipi-
tated using anti-caveolin-1 and anti-annexin II fol-
lowed by immunoblot analysis. To detect phospho-
rylated amino acids, the blots were ¢rst incubated
with an antibody directed against a particular phos-
phorylated amino acid (mouse anti-phosphoserine or
mouse anti-phosphotyrosine) followed by quantita-
tion using ECL and imaging densitometry. The pri-
mary and secondary antibodies were then removed
from the immunoblot using stripping bu¡er (65 mM
Tris, pH 6.8, 1.5% SDS and 150 mM 2-mercapto-
ethanol for 30 min at room temperature) before re-
blocking. To assure adequate removal of antibodies,
immunoblots were screened by reblocking and then
incubating with secondary antibody followed by
ECL. To normalize for the degree of serine and ty-
rosine phosphorylation, immunoblots were then in-
cubated with antibodies against caveolin-1 or annex-
in II. The degree of protein phosphorylation was
reported as a ratio of speci¢c serine and tyrosine
phosphorylation to the amount of protein.
2.7. Cholesterol determination
The isolated TIFF was extracted with hexane:iso-
propanol (3:2) for 1 h, followed by centrifugation.
The organic solvent was removed, dried, and spotted
onto a thin-layer chromatography plate (Redi-Plate,
250 Wm Silica Gel G, Fisher Scienti¢c). Neutral lipids
were separated using hexane:diethyl ether:glacial
acetic acid (100:30:1.1). Unesteri¢ed cholesterol
and cholesteryl ester were localized by comparison
with standards after staining with iodine vapors.
After destaining, unesteri¢ed cholesterol was col-
lected into glass culture tubes and extracted with
3 ml hexane and 1 ml water, with the hexane phase
being separated into a separate glass tube. Cholester-
ol concentrations were then determined using the
cholesterol oxidase method [28]. Brie£y, to each
tube was added 0.4 ml of assay reagent (0.1 ml chol-
esterol oxidase (8 U/ml), 0.1 ml peroxidase (3000 U/
ml), 1.0 ml of hydroxyphenylacetic acid (1.5 mg/ml)
and 8.8 ml 0.05 M sodium phosphate pH 7.0) fol-
lowed by incubation for 20 min at room tempera-
ture. The reaction was terminated by adding 0.8 ml
of 0.5 N NaOH. A Perkin-Elmer Model LS-40 Flu-
orescence Spectrometer (excitation 325 nm and emis-
sion 415 nm) was used for measuring £uorescence.
The unknown cholesterol concentrations were deter-
mined using cholesterol standards and linear regres-
sion analysis.
2.8. Phospholipid determination
Phospholipids, which do not migrate in the solvent
system utilized for separation of sterols, were col-
lected from the origin and extracted using Folch re-
agent (chloroform:methanol, 2:1). The extracted lip-
ids were spotted onto a heat activated (100‡C for 30
min) 250 Wm Silica Gel H thin-layer chromatography
plate (Analtech), and the phospholipids (phosphatid-
ylcholine, lysophosphatidylcholine, sphingomyelin,
phosphatidylserine, phosphatidylethanolamine) were
separated using chloroform:methanol:glacial acetic
acid:water (100:60:16:8) as the solvent system.
This solvent system does not allow adequate separa-
tion of phosphatidic acid and cardiolipin from the
other phospholipids, since both migrate together at
the solvent front. Therefore, these two lipids were
collected and extracted from the resin using chloro-
form and reapplied to a 250 Wm Silica Gel G plate
and separated using petroleum ether:diethylether:
zglacial acetic acid (90:10:5). After staining with io-
dine vapors, the resin containing the lipids was
scraped into a separate tube and analyzed for phos-
phorus by adding 150 Wl of concentrated perchloric
acid (60%) and incubated for 1 h at 170‡C [29]. After
incubation, 1.7 ml of water, 0.4 ml acid molybdate
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solution (1.25% w/v ammonium molybdate in 2.5 M
sulfuric acid) and 0.1 ml Fiske Subbarow reducer
solution (1 g/6.3 ml of water) were added to each
sample and reincubated at 95‡C for 15 min. Samples
were read at a wavelength of 820 nm and the con-
centration of phosphorus from each sample was de-
termined by extrapolation using a phosphorus stand-
ard (Sigma Diagnostics) analyzed in parallel.
2.9. Diacylglycerol determination
The concentration of diacylglycerol was deter-
mined using the Triglyceride/Glycerol Assay Kit
(Sigma Diagnostics). Brie£y, diacyglycerol was ex-
tracted from the resin using hexane and hydrolyzed
by incubating with 0.5 ml of 0.1 N KOH at 80‡C for
1 h. Upon cooling to room temperature, 1 ml of 0.15
M MgSO4 was added to form a precipitate that was
removed by centrifugation to obtain a supernatant
fraction containing the resultant glycerol. To 0.2 ml
of this supernatant was added 1.0 ml of assay solu-
tion (5 min at room temperature) and read at 340
nm. To each of the respective samples was added 4 Wl
of glycerokinase responsible for oxidizing NADH to
NAD, followed by reincubation at room temperature
for 15 min before reading absorbance again at 340
nm. The di¡erence between the latter and former
absorbances were used to calculate the absolute
amount of glycerol derived from the hydrolysis of
diacylglycerol.
2.10. Statistical analysis
All quantitative data is represented as the
mean þ S.D. of four separate mouse livers isolated
from each of the three di¡erent genotypes (homo-
zygous normal, heterozygous and homozygous af-
fected). Each of the isolated TIFF samples was de-
rived from a corresponding liver homogenate.
Signi¢cant di¡erences between groups of data were
determined using the two-tailed Student’s t-test as-
suming equal variance.
3. Results
3.1. Expression of caveolin-1 and annexin II in liver
homogenates and the TIFF
The altered expression of caveolin-1 and annexin
II in heterozygous and homozygous liver homoge-
nates is shown in Fig. 1. Caveolin-1 expression is
elevated in both heterozygous (4.9 fold, P = 0.0004)
and homozygous livers (1.6 fold, P = 0.0153). In con-
Fig. 1. Altered expression of caveolin-1 (top) and annexin II
(bottom) in heterozygous and homozygous liver homogenates
and the relative amount associated with the corresponding
TIFF. Equal amounts of liver homogenate protein and TIFF
derived protein from four sets of mice were separated in paral-
lel using 10% SDS-PAGE and transferred to nitrocellulose for
immunoblot analysis. Primary antibodies, mouse anti-caveolin-1
IgG and mouse anti-annexin II IgG, were detected using perox-
idase-conjugated goat anti-mouse IgG developed with ECL. A
representative immunoblot showing the relative amount of cav-
eolin-1 and annexin II in the liver homogenate and the isolated
TIFF is provided for normal, heterozygous and homozygous
animals, respectively. Quantitation was performed using an
imaging densitometer, where the background optical density
was subtracted from each sample. Shown is the mean þ S.D. of
the optical density normalized to protein for the three geno-
types. White bars represent homozygous normal (+/+), diago-
nally hatched bars represent heterozygous (+/3) and black bars
represent homozygous a¡ected (3/3).
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trast, the expression of annexin II was increased only
in homozygous livers (23 fold, P = 4.97U1038) com-
pared to the expression of annexin II in normal and
heterozygous livers. The amount of caveolin-1 in the
heterozygous TIFF was increased (1.8 fold,
P = 5.5U1035) compared to the amount of caveo-
lin-1 associated with the normal TIFF; the amounts
of caveolin-1 in the normal and homozygous TIFFs
were similar. The amount of annexin II associated
with the homozygous TIFF was signi¢cantly in-
creased (4.3 fold, P = 0.0014) compared to the
amount of annexin II associated with the normal
and heterozygous TIFF.
3.2. Phosphoamino acid analysis of caveolin-1 and
annexin II
Using antibodies generated against phosphoserine
and phosphotyrosine, we determined quantitatively
the degree of caveolin-1 and annexin II phosphoryl-
ation after selective immunoprecipitation from the
TIFF. To accurately determine the amount of phos-
phoserine and phosphotyrosine associated with cav-
eolin-1 and annexin II, immunoblots were initially
probed with antibodies against a respective phos-
phoamino acid, stripped of both primary and sec-
ondary antibodies, and reprobed with antibody
against the protein of interest to normalize for pro-
tein. This procedure assured that alterations in ami-
no acid phosphorylation were not the result of di¡er-
ences in the amount of protein detected during
immunoblot analysis. The degree of serine phospho-
rylation in caveolin-1 immunoprecipitated from the
homozygous TIFF was signi¢cantly increased com-
pared to caveolin-1 from normal (1.84 fold,
P = 0.0003) and heterozygous TIFFs (1.96 fold,
P = 0.0403) (Fig. 2). No signi¢cant di¡erence in cav-
eolin-1 tyrosine phosphorylation was detected. The
degree of annexin II tyrosine phosphorylation was
increased in the homozygous TIFF compared to an-
nexin II from the normal TIFF (2.41 fold,
P = 0.0155). Although annexin II from the homozy-
gous TIFF was increased in tyrosine phosphoryla-
tion compared to annexin II from the heterozygous
TIFF (1.97 fold, P = 0.0600), the measured increase
was not statistically signi¢cant. There was no signi¢-
cant di¡erence in the degree of annexin II serine
phosphorylation between the three genotypes.
3.3. Expression of protein kinases in liver
homogenates
The expression of several protein kinases (PKCK,
PKCN, PKCO, PKCj, PKA-cs, CK IIK and pp60-src)
was measured in liver homogenates prepared from
normal, heterozygous and homozygous mice (Fig.
3). The expression of PKCK in heterozygous and
homozygous liver homogenates was signi¢cantly in-
creased compared to normal liver homogenates (3.7
fold, P = 0.0130 and 3.5 fold, P = 0.0004, respec-
tively). The expression of PKCN from homozygous
livers was increased approximately 35 fold compared
to normal (P = 0.0002) and heterozygous (P = 0.0006)
livers. The minor higher molecular weight bands,
present in both the PKCK and PKKj immunoblots,
are believed to represent phosphorylated isoforms. In
both instances, these minor bands were quantitated
along with the major protein kinase band. The ex-
pression of PKCO was decreased in heterozygous and
homozygous livers (1.4 fold, P = 0.0320 and 2.2 fold,
Fig. 2. Phosphoamino acid analysis of caveolin-1 and annexin
II associated with the TIFF derived from normal, heterozygous
and homozygous livers. Caveolin-1 and annexin II were immu-
noprecipitated from four sets of TIFFs and then separated us-
ing 10% SDS-PAGE and transferred to nitrocellulose for immu-
noblot analysis. Primary antibodies, mouse anti-phosphoserine
IgG and mouse anti-phosphotyrosine IgG, were detected using
peroxidase-conjugated goat anti-mouse IgG developed with
ECL. To normalize for the amount of immunoprecipitated pro-
tein, blots were stripped of primary and secondary antibodies
and reprobed for either caveolin-1 or annexin II. Shown is the
mean þ S.D. of phosphoamino acid measured after normalizing
for the amount of caveolin-1 or annexin II. White bars repre-
sent homozygous normal (+/+), diagonally hatched bars repre-
sent heterozygous (+/3) and black bars represent homozygous
a¡ected (3/3).
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P = 0.0126, respectively) compared to normal. The
expression of PKCj was increased in heterozygous
livers (20 fold, P = 1.72U1037) compared to normal
liver. The expression of PKA-cs was not signi¢cantly
di¡erent (Pv 0.0500) in heterozygous and homo-
zygous liver homogenates compared to normal liver
homogenates. The expression of CK IIK in homo-
zygous liver homogenates was decreased (1.7 fold,
Fig. 3. Relative amounts of select protein kinases expressed in normal, heterozygous and homozygous liver homogenates. Equal
amounts of liver homogenate protein from four sets of mice were separated in parallel using 10% SDS-PAGE and transferred to ni-
trocellulose for immunoblot analysis. Primary antibodies against select protein kinases were detected using peroxidase-conjugated goat
anti-mouse IgG developed with ECL. A representative immunoblot showing the relative amount of each protein kinase in the liver ho-
mogenate is provided for normal, heterozygous and homozygous animals, respectively. Quantitation was performed using an imaging
densitometer, where the background optical density was subtracted from each sample. Shown is the mean þ S.D. of the optical density
normalized to protein from the three genotypes. White bars represent homozygous normal (+/+), diagonally hatched bars represent
heterozygous (+/3) and black bars represent homozygous a¡ected (3/3). Arrowheads in the pp60-src panels represent the
phosphorylated (higher band) and unphosphorylated (lower band) forms.
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P = 0.0013) compared to normal homogenates. pp60-
src was resolved into two distinct bands during im-
munoblot analysis: a lower molecular weight band
believed not to be phosphorylated and a higher mo-
lecular weight band representing the phosphorylated
and active pp60-src [30]. The lower molecular weight
form of pp60-src was increased 16 fold (P = 0.0002)
in heterozygous livers and 5.2 fold (P = 0.0012) in
homozygous livers compared to normal liver homog-
enates, while the higher molecular weight form of
pp60-src was increased 6.5 fold (P = 0.0003) in heter-
ozygous livers and 2.6 fold (P = 0.0130) in homo-
zygous liver homogenates compared to normal liver
homogenates.
3.4. Relative amount of protein kinases associated
with the TIFF
Only four of the eight protein kinases examined
were found in the TIFF (Fig. 4). There was no sig-
ni¢cant di¡erence among the three genotypes in the
amount of PKCK measured in the TIFFs. For
PKCj, an increased amount was found associated
with the heterozygous TIFF (15 fold, P = 0.0041)
and the homozygous TIFF (2.0 fold, P = 0.0155)
compared to the normal TIFF. CK IIK was in-
creased (1.99 fold, P = 0.0224) only in the hetero-
zygous TIFF compared to the normal TIFF. Finally,
only the lower molecular weight form of pp60-src
was signi¢cantly represented in the TIFF. No signi¢-
cant di¡erence (Pv 0.05) in the relative amount of
pp60-src was measured when comparing the TIFFs
isolated from normal, heterozygous and homozygous
livers.
3.5. Amount of total protein and relative enrichment
of speci¢c proteins in the TIFF
The amount of total protein recovered in the nor-
mal, heterozygous, and homozygous TIFFs was, re-
Fig. 4. Relative amounts of select protein kinases associated with the TIFF isolated from normal, heterozygous and homozygous liv-
ers. Equal amounts of the TIFF derived protein from four sets of mice were separated in parallel using 10% SDS-PAGE and trans-
ferred to nitrocellulose for immunoblot analysis. Primary antibodies against select protein kinases were detected using peroxidase-con-
jugated goat anti-mouse IgG developed with ECL. A representative immunoblot showing the relative amount of select protein kinases
in the isolated TIFF is provided for normal, heterozygous and homozygous animals, respectively. Quantitation was performed using
an imaging densitometer, where the background optical density was subtracted from each sample. Shown is the mean þ S.D. of the
optical density normalized to protein for the three genotypes. White bars represent homozygous normal (+/+), diagonally hatched
bars represent heterozygous (+/3) and black bars represent homozygous a¡ected (3/3).
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spectively, 2.4, 2.0% and 0.9% that found in the total
homogenates (Table 1). Caveolin-1 was enriched in
both the normal and homozygous TIFFs but not in
the heterozygous TIFF. This indicates that the in-
creased expression of caveolin-1 measured in the het-
erozygous homogenate does not result in an in-
creased distribution of caveolin-1 to the TIFF.
However, caveolin-1 levels in the heterozygous
TIFF are still greater than levels in the normal or
homozygous TIFF (Fig. 1). Annexin II is not en-
riched within any of the TIFFs suggesting it was
solubilized with Triton X-100 detergent during
TIFF isolation. Of the four protein kinases found
in the TIFF (PKCK, PKCj, CK IIK, and pp60-
src), only CK IIK was enriched compared to total
liver homogenates.
3.6. Concentration of select lipids in the TIFF
The masses of select lipids in the TIFF derived
from normal, heterozygous and homozygous liver
homogenates are shown in Table 2. The concentra-
tion of common glycerolipids (phosphatidylcholine,
phosphatidylserine, phosphatidylethanolamine) and
lysophosphatidylcholine were similar among the
three genotypes. Unesteri¢ed cholesterol and sphin-
gomyelin, which have previously been shown to be
elevated in liver homogenates of mice a¡ected with
NPC, were increased approximately 15 fold
(P = 0.0012) and 3 fold (P = 0.0012), respectively, in
the homozygous TIFF compared to the normal
TIFF. The concentration of diacylglycerol was in-
creased 6.6 fold (P = 0.0016) in the TIFF from ho-
mozygous livers compared to the TIFF from normal
livers. None of the lipids analyzed in the TIFF
derived from heterozygous livers were signi¢cantly
increased in concentration compared to the TIFF
derived from normal livers. Additional lipids (mono-
acylglycerol, triacylglycerol, phosphatidic acid and
cardiolipin) were below the limits of mass detection.
Table 2
Quantitation of speci¢c lipids associated with the isolated TIFF derived from livers of normal, heterozygous and homozygous mice
Lipid Normals Heterozygous Homozygous
Cholesterol 7.71 þ 0.26 6.45 þ 2.33 1.06 þ 34.3*
Phosphatidylcholine 2.90 þ 0.78 2.94 þ 1.45 3.43 þ 0.82
Phosphatidylserine 1.22 þ 0.13 1.17 þ 0.42 1.31 þ 0.06
Phosphatidylethanolamine 1.04 þ 0.14 0.92 þ 0.57 1.15 þ 0.24
Lysophosphatidylcholine 0.86 þ 0.06 0.85 þ 0.28 0.99 þ 0.16
Sphingomyelin 1.20 þ 0.15 0.96 þ 0.25 3.61 þ 0.83*
Diacylglycerol 1.10 þ 0.45 1.25 þ 0.24 6.68 þ 1.82*
Detailed methods utilized to isolate the TIFFs from the liver homogenates with subsequent determination of lipid mass are described
in Section 2. The concentration of each lipid is expressed as Wg/mg protein. Data is represented as the mean þ S.D. of TIFFs isolated
from four di¡erent liver homogenates within a speci¢ed genotype. Statistically signi¢cant di¡erences, P6 0.050, in the concentration
of speci¢ed lipids derived from TIFFs isolated from normal and homozygous mice are indicated (*). Monoacylglycerol, triacylglycerol,
phosphatidic acid, cardiolipin and fatty acids were not detected within any of the TIFF samples.
Table 1
Analysis for enrichment of speci¢c proteins in the TIFF fraction vs. total livers homogenates
Mouse
genotype
Homogenate
protein (mg)
TIFF
protein (mg)
Caveolin-1 Annexin II PKCK PKCj CK IIK pp60-src
+/+ 53.24 þ 7.16 1.28 þ 0.14 2.97 þ 0.28 0.11 þ 0.08 0.56 þ 0.17 0.35 þ 0.14 1.67 þ 0.35 0.83 þ 0.41
+/3 69.29 þ 33.39 1.41 þ 0.61 0.93 þ 0.03 0.16 þ 0.04 0.20 þ 0.03 0.26 þ 0.10 3.42 þ 1.06 0.02 þ 0.02
3/3 36.80 þ 2.57 0.34 þ 0.05 1.62 þ 0.14 0.03 þ 0.01 0.14 þ 0.11 0.34 þ 0.08 2.73 þ 1.14 0.12 þ 0.14
Liver homogenates and the corresponding TIFF from each liver were prepared as described in Section 2. Protein derived from each
of the homogenates and the corresponding TIFFs were used for the determination of protein and the relative amount of select pro-
teins associated with the TIFF. Data is represented as the mean þ S.D. of four di¡erent homogenates and the corresponding TIFF.
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4. Discussion
Heterozygous and homozygous mice with NPC
have an increased expression of caveolin-1 in liver
homogenates [8]. These results can now, perhaps,
be partially explained by recent studies indicating
that LDL-derived cholesterol upregulates the expres-
sion of caveolin-1 in normal cells [31^33]. The con-
clusion from these latter experiments was that cav-
eolin-1, in association with plasma membrane
caveolae, is responsible for maintaining cholesterol
levels by promoting the e¥ux of excess intracellular
unesteri¢ed cholesterol. This relationship between
LDL-cholesterol and caveolin-1 levels may explain
the increase in caveolin-1 seen in NPC. Since the
transport of LDL-derived cholesterol is impaired in
NPC and cells accumulate LDL-derived cholesterol,
this excess intracellular cholesterol may result in an
increase in caveolin-1 expression. However, the ele-
vation of caveolin-1 in heterozygous NPC liver ho-
mogenates and ¢broblasts is greater than that seen in
the homozygous genotype, even though accumula-
tion of cholesterol is not detected in the heterozygous
state. It has been shown, however, that the hetero-
zygous genotype is not without its e¡ects on choles-
terol tra⁄cking, and that some cholesterol accumu-
lation does occur [34,35]. Heterozygous cells may be
‘sensing’ this cholesterol accumulation. Since there is
one functional Npc1 gene in heterozygous cells, this
may in some way result in a greater expression of
caveolin-1 than that seen in homozygous cells to
‘compensate’ for the de¢cient amount of NPC1 pro-
tein. To discern further the mechanisms of this cel-
lular response, we investigated the role of potential
regulatory proteins associated with caveolae and cav-
eolin-1 containing vesicles that may also serve to
modulate intracellular cholesterol tra⁄cking path-
ways.
Our present study demonstrates an increased ex-
pression of annexin II in homozygous NPC livers.
Work performed by other investigators have sug-
gested that an increased expression of annexin II in
hepatocytes may result from hepatocyte proliferation
secondary to liver damage (a state that may indeed
exist in NPC), but these studies have also demon-
strated an upregulation of annexin I [36]. We were
unable to detect annexin I within any of the liver
homogenates, suggesting that the altered expression
of annexin II may, like caveolin-1, be in response to
the NPC cholesterol tra⁄cking defect. Although an-
nexin II has been found associated with caveolae,
our results indicate that annexin II was not enriched
within the isolated TIFF. A possible explanation for
this ¢nding is that annexin II is capable of being
solubilized, unlike caveolin-1, with Triton X-100 dur-
ing isolation of the TIFF [37]. Other studies indicate
that the majority of cellular annexin II is associated
with endosomal membranes, where it participates in
the reorganization of vesicular structures by facilitat-
ing the fusion of lipid bilayers. The nature of these
endosomal membranes may have di¡erent detergent
insolubility characteristics than caveolae [38].
Recent studies demonstrate that annexin II partic-
ipates in cholesterol metabolism [20]. Traditionally,
annexins were classi¢ed only as calcium and phos-
pholipid-binding proteins [39,40], but a novel mech-
anism has been described demonstrating that a sig-
ni¢cant portion of total cellular annexin II is tightly
associated with membranes in a Ca2-independent
manner [20]. It was concluded that a cholesterol-de-
pendent binding mechanism mediated by the N-ter-
minal domain of annexin II maybe speci¢c for mem-
brane domains rich in cholesterol, such as caveolae.
Although the cholesterol-dependent binding mecha-
nism is uncharacterized, annexin II may interact
directly with cholesterol and participate in the trans-
port of cholesterol between subcellular compart-
ments. Because of the lack of information concerning
the exact function of annexin II, we are limited in
our conclusions regarding its role in NPC beyond
that of its participation in endosomal membrane
and vesicular transport processes including, perhaps,
those involving the NPC1 protein [41^43].
The functions of caveolin-1 and annexin II are
believed to be regulated in part by serine and tyro-
sine phosphorylation [25,44]. Serine phosphorylation
of caveolin-1 has been shown to £atten caveolae and
prevent folate uptake by potocytosis [45], while tyro-
sine phosphorylation of caveolin-1 may facilitate the
docking of speci¢c signaling molecules [46]. Likewise,
the phosphorylation of serine and tyrosine residues
on annexin II is believed to in£uence aspects of mem-
brane binding, vesicle aggregation and vesicle inter-
nalization [47^49]. Comparison of the phosphoryla-
tion of caveolin-1 in the normal, heterozygous, and
homozygous TIFF reveals increased phosphorylation
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on serine residues in the homozygous TIFF, but not
on tyrosine residues, suggesting the involvement of a
serine speci¢c kinase. The primary structure of cav-
eolin-1 contains two serine residues, both residing in
a phosphorylation consensus sequence and £anked
by a regulatory sca¡olding domain [21,23]. One of
these residues, Ser-37, represents a PKC consensus
site, while the other, located at Ser-88, is believed
to be phosphorylated by CK IIK. Since studies indi-
cate that caveolin-1 is not a direct substrate for PKC,
the increased serine phosphorylation that was de-
tected on caveolin-1 is most likely catalyzed by CK
IIK at Ser-88 [23]. It has been demonstrated that
activation of PKC modulates both the morphology
and function of caveolae, and that phosphorylation
of CK IIK by PKC may represent a phosphorylation
cascade that facilitates this event [11,23,26]. Indeed,
CK IIK is a substrate for PKCK and both protein
kinases are associated with caveolae [23,50]. An addi-
tional explanation for the activation of CK IIK and
subsequent serine phosphorylation of caveolin-1 is
somewhat more non-speci¢c. Sphingosine and sphin-
ganine, which are potent activators of CK IIK [51],
have been shown to be elevated in the livers of mice
with NPC and NPC ¢broblasts grown in culture [52^
54]. Whatever the mechanism, serine phosphoryla-
tion of caveolin-1 may impute speci¢c properties
that negatively regulate the normal transport of un-
esteri¢ed cholesterol.
With respect to the phosphorylation of annexin II,
our results indicate that tyrosine phosphorylation of
annexin II in the homozygous TIFF was signi¢cantly
increased compared to annexin II in the normal and
heterozygous TIFFs, while the level of serine phos-
phorylation remained unchanged. Annexin II is
known to be a substrate for speci¢c protein tyrosine
kinases, most notably (1) pp60-src, (2) the insulin
receptor kinase, and (3) the PDGF receptor kinase,
all of which phosphorylate Tyr-23 located near the
N-terminal domain [25,55,56]. Although studies sug-
gest that insulin-induced tyrosine phosphorylation of
annexin II may regulate the internalization and sort-
ing mechanism for this receptor, the precise role of
annexin II tyrosine phosphorylation remains to be
determined.
Enhanced phosphorylation of both caveolin-1 and
annexin II associated with the homozygous TIFF
prompted us to investigate the expression and distri-
bution of select serine and tyrosine protein kinases.
As our results demonstrate, a number of these pro-
tein kinases were altered to some degree within het-
erozygous and homozygous livers which may provide
an explanation for the increased phosphorylation of
caveolin-1 and annexin II. Compared to normal ho-
mogenates, the amounts of PKCK and pp60-src were
increased in both heterozygous and homozygous liv-
er homogenates, while the amount of PKCj and
PKCN were selectively increased in heterozygous or
homozygous liver homogenates, respectively. A pos-
sible explanation for the increased expression of
these protein kinases could be related to recent stud-
ies that have established a link between caveolin-1
and the inhibition of speci¢c protein kinases
[57,58]. It is believed that the caveolin-1 sca¡olding
domain interacts and inhibits the enzymatic activity
of particular protein kinases (PKCK, PKCj and
pp60-src, but not PKCO). Therefore, it is possible
that the increased expression of caveolin-1 we
previously measured in heterozygous and homo-
zygous livers has a role in negatively regulating pro-
tein kinase activity, and that the increased protein
expression of these protein kinases is an attempt to
compensate for this inhibitory e¡ect on catalytic ac-
tivity.
Since the homozygous TIFF contained an in-
creased concentration of diacylglycerol, it is possible
that certain PKC isotypes associated with the TIFF
could be modulated by this lipid. Investigators work-
ing with monkey kidney epithelial cells have found
that an increased concentration of PMA displaces
PKCK from caveolae [26]. This would at least pro-
vide an explanation for the decreased amount of
PKCK associated with the homozygous TIFF, but
would not provide an explanation for the decreased
amount of PKCK associated with the heterozygous
TIFF, unless it was displaced by a resident protein
kinase, such as PKCj upon activation within the
heterozygous TIFF. Since PKCj is activated inde-
pendent of calcium and diacylglycerol, the induced
translocation of this particular PKC isotype to the
TIFF is intriguing and may yield important regula-
tory information regarding the pathophysiology of
NPC. Importantly, other inborn errors of metabo-
lism, such as mucolipidosis type 4 and Zellweger
syndrome, have demonstrated major perturbations
in PKC-mediated signal transduction which are be-
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lieved to contribute to pathogenesis of these disor-
ders [59,60].
Of the protein kinases examined, the expression
and distribution of CK IIK and pp60-src are of pri-
mary importance in delineating the mechanism re-
sponsible for serine phosphorylation of caveolin-1
and tyrosine phosphorylation of annexin-II, respec-
tively. The relative expression of CK IIK was de-
creased in homozygous homogenates, but the
amount of CK IIK associated with the homozygous
TIFF was similar to the amount associated with the
normal TIFF. Based solely on these results, we are
unable to provide a plausible explanation accounting
for the increased serine phosphorylation of caveolin-
1 in the homozygous TIFF, besides the possibility
that sphingosine and sphinganine are activating CK
IIK as previously described. With respect to pp60-src,
examination of the immunoblots revealed increased
amounts of two forms of pp60-src due to phospho-
rylation: a tight doublet representing an inactive
(lower molecular weight) form and an active (higher
molecular weight) form of pp60-src [61]. By measur-
ing both proteins independently and comparing the
relative expression among the three genotypes, we
determined that the inactive and active forms of
pp60-src were expressed highest in heterozygous liv-
ers, while homozygous livers expressed intermediate
levels. Distribution of pp60-src to the TIFF indicated
that only the lower molecular weight form was
present and in similar amounts, consistent with stud-
ies demonstrating that caveolae, and caveolin-1 in
particular, may represent a sca¡olding structure
that holds the inactive form of pp60-src [62].
Our previous results have indicated that unesteri-
¢ed cholesterol was enriched within the TIFF derived
from homozygous livers. To complete the analysis of
lipids associated with the TIFF, we determined the
mass of additional glycerolipids and sphingolipids in
an attempt to further characterize the role of this
subcellular compartment in NPC. In doing so, we
found that the concentration of major phospholipids
(phosphatidylcholine, phosphatidylserine, phospha-
tidylethanolamine, lysophosphatidylcholine) were
similar among the three genotypes analyzed,
although sphingomyelin was signi¢cantly increased
in the TIFF derived from homozygous livers. This
result would be consistent with an increased concen-
tration of unesteri¢ed cholesterol in the homozygous
TIFF, since these two lipids form a tight complex
[63]. As described above, our results indicate that
diacylglycerol is elevated in the TIFF derived from
homozygous livers, which may in part contribute to
the altered distribution and activity of speci¢c PKC
isotypes.
The function of the Npc1 gene product is currently
uncharacterized, but the primary amino acid se-
quence indicates a sterol-sensing domain and other
important regulatory domains that will no doubt
have an important role in modulating cholesterol
homeostasis. With this study, we describe di¡erential
alterations in the expression, phosphorylation and
localization of caveolin-1, annexin II and protein
kinases that may have an important role in diverse
signal transducing pathways. Alteration in these pro-
teins may be involved in modulating and controlling
intracellular cholesterol tra⁄cking, speci¢cally the
distribution of cholesterol to various cellular com-
partments. How these proteins are regulated by the
NPC1 protein is an important ¢rst step in de¢ning
key processes in maintaining cholesterol homeostasis
and the molecular basis for NPC disease.
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